Zobrazeno 1 - 7
of 7
pro vyhledávání: '"A. H. Palumbo"'
Purpose: The aim of the International Myeloma Working Group was to develop practical recommendations for the diagnosis and management of multiple myeloma–related renal impairment (RI). Methods: Recommendations were based on published data through D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::48c145964f6a240a1f15959427f45cd0
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3085510
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3085510
Clinical outcomes for patients with multiple myeloma (MM) have improved substantially since the introduction of novel agents including the proteasome inhibitor bortezomib and the immunomodulatory drugs thalidomide and lenalidomide. However, most pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::13b3a3901e963b7ccb4616bd4802d213
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3088706
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3088706
Publikováno v:
Health affairs (Project Hope). 32(9)
Community leaders in Calhoun County, Michigan, identified access to dental care as an acute local need and in early 2007 organized Calhoun County Dentists' Partnership. A group of stakeholders developed a program centered on local dentists who donate
Introduction of the proteasome inhibitor bortezomib and the immunomodulatory drugs thalidomide and lenalidomide has substantially improved outcomes for patients with multiple myeloma. As a result, these drugs have become cornerstones of current antim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::7a05793768b9de17602221b1dd82c63b
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3130171
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3130171
Autor:
E Sala-Planell, Ch Caulin, P Duroux, G Tempelhoff, B Blettery, J C Ducreux, A Le Hellocco, P Leborgne, A. Barret, Giancarlo Agnelli, D. Robert, M d’Addato, Giuseppe G. Nenci, M Vigo, O Mericq, Ph Bachet, H Muntlak, P Sourou, M Chagny, J Bensaid, Ph Girard, H Palumbo, Jacques Ninet, Jean-François Bergmann, G Janvier, F Bachmann, A Rosendo-Carrera, Paolo Prandoni, J C Gaux, Bernard Boneu, A Ruol, A Torres-Gomez, J Gouffault, M C Laprevote-Heully
Publikováno v:
Thrombosis and Haemostasis. 65:251-256
SummaryThe standard treatment of deep vein thrombosis is given by continuous intravenous infusion of unfractionated heparin. This entails hospitalisation, nursing care, immobility and repeated laboratory tests (e.g. activated partial thromboplastin t
Publikováno v:
Physical Review Letters. 45:474-477
Inelastic-neutron-scattering studies on ${\mathrm{Fe}}_{x}{\mathrm{Cr}}_{1\ensuremath{-}x}$ for $x=0.34 \mathrm{and} 0.26$ reveal well-defined spin-wave excitations in the ferromagnetic regime and show a significant decrease of the spin-wave stiffnes
Autor:
Mateos, Maria-Victoria, Blacklock, Hilary, Schjesvold, Fredrik, Oriol, Albert, Simpson, David, George, Anupkumar, Goldschmidt, Hartmut, Larocca, Alessandra, Chanan-Khan, Asher, Sherbenou, Daniel, Avivi, Irit, Benyamini, Noam, Iida, Shinsuke, Matsumoto, Morio, Suzuki, Kenshi, Ribrag, Vincent, Usmani, Saad Z, Jagannath, Sundar, Ocio, Enrique M, Rodriguez-Otero, Paula, San Miguel, Jesus, Kher, Uma, Farooqui, Mohammed, Liao, Jason, Marinello, Patricia, Lonial, Sagar, KEYNOTE-183 Investigators, Nicol A, Grigoriadis G, Catalano J, LeBlanc R, Elemary M, Bahlis N, Facon T, Karlin L, Ribrag V, Attal M, Goldschmidt H, Engelhardt M, Weisel K, Mackensen A, Nagler A, Ben Yehuda D, Avivi I, Benyamini N, Magen-Nativ H, Palumbo A, Cavo M, Tobinai K, Iida S, Chou T, Suzuki K, Kosugi H, Taniwaki M, Sunami K, Matsumoto M, Ando K, Ganly P, Blacklock H, Simpson D, George A, Schjesvold F, Gjertsen B, Lahuerta J, Blade J, Oriol Rocafiguera A, Mateos M, Rodriguez-Otero P, Larson S, Atanackovic D, Devarakonda S, Bitran J, Zonder J, Morganstein N, Hay M, Chanan-Khan A, Saylors G, Kio E, Oliff I, Kirkel D, Shtivelband M, Yuen C, Yee A, Shah J, Htut M, Raza S, Chhabra S, Stiff P, Hari P, Bank B, Malek E, Gasparetto C, Faroun Y, Sherbenou D, Kreisle W, Singhal S, Rosenblatt J, Usmani S, Lee W, Safah H, Lutzky J, Suh J, Pan D, Baron A, Manges R, Steis R, Oliveira M, Moreb J, Callander N, Anz B, Raptis A, Stampleman L, Melear J, Boyd T, Garbo L, Klein L, Shao S, Lyons R, McIntyre K, Tarantolo S, Yasenchak C, Yimer H.
Publikováno v:
Ann Transl Med
Lancet Haematology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Lancet Haematology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Summary Background Pomalidomide and dexamethasone is a standard of care for patients with multiple myeloma in whom bortezomib and lenalidomide treatment has failed. KEYNOTE-183 assessed efficacy and safety of pomalidomide and dexamethasone with or wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21f1362cea0664cfe2470bd04f49b410
https://hdl.handle.net/2318/1742132
https://hdl.handle.net/2318/1742132